MOON vs. GERM ETF Comparison

Comparison of Direxion Moonshot Innovators ETF (MOON) to ETFMG Treatments Testing and Advancements ETF (GERM)
MOON

Direxion Moonshot Innovators ETF

MOON Description

The Direxion Moonshot Innovators ETF offers exposure to the 50 most innovate US companies at the forefront of changing our lives today, and tomorrow, by identifying the companies both pursuing innovation, and having the potential to disrupt existing technologies and/or industries. These 50 companies selected for inclusion are deemed to have the highest "early-stage composite innovation scores" and the they span themes and emerging sectors such as smart transportation, clean power, and the human evolution. The early stage composite score is based on a company’s "allocation to innovation" and "innovation sentiment" score.

Grade (RS Rating)

Last Trade

$10.33

Average Daily Volume

18,830

Number of Holdings *

10

* may have additional holdings in another (foreign) market
GERM

ETFMG Treatments Testing and Advancements ETF

GERM Description GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.

Grade (RS Rating)

Last Trade

$19.16

Average Daily Volume

1,248

Number of Holdings *

2

* may have additional holdings in another (foreign) market
Performance
Period MOON GERM
30 Days 8.34% 3.00%
60 Days 1.77% 3.68%
90 Days 16.07% -2.06%
12 Months -26.00% -0.17%
0 Overlapping Holdings
Symbol Grade Weight in MOON Weight in GERM Overlap
Compare ETFs